logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
F

Fredrik Tiberg

Camurus AB

53H指数
179论文数
7.6K被引数
收录论文 79
发表时间
logo
P274 - ECE_2789 - CAM2029 octreotide subcutaneous depot maintains biochemical and symptom control across a 4-week dosing interval and for intervals >28 days: data from the ACROINNOVA 2 trialP274 - ECE_2789 - CAM2029奥曲肽皮下缓释剂在4周给药间隔及>28天间隔内维持生化指标和症状控制：ACROINNOVA 2试验数据
errEuropean Journal of Endocrinology
IF5.2
err2026-08-10
err0
errOAAI
errMônica Gadelha; Diego Ferone; Maria Fleseriu; Pietro Maffei; Robert D Murray; Jochen Seufert; Julie M Silverstein; Joanna L Spencer-Segal; Jacob Råstam; Alberto M Pedroncelli; Fredrik Tiberg; Beverly M K Biller
err分享
err收藏
RC3.4 - ECE_1029 - Effect of CAM2029 on long-term biochemical and symptom control in patients with acromegaly according to prior injectable somatostatin receptor ligandRC3.4 - ECE_1029 - CAM2029对肢端肥大症患者长期生化控制和症状控制的影响，根据既往注射用生长抑素受体配体
errEuropean Journal of Endocrinology
IF5.2
err2026-08-10
err0
errOAAI
errMaria Fleseriu; Irina Bancos; Timo Deutschbein; Diego Ferone; Mônica Gadelha; Aleksandra Gilis-Januszewska; Elena Isaeva; Pinar Kadioglu; Robert D Murray; Joanna L Spencer-Segal; Jacob Råstam; Maria Harrie; Agneta Svedberg; Alberto M Pedroncelli; Fredrik Tiberg; Beverly M K Biller
err分享
err收藏
P266 - ECE_1022 - Long-term safety, biochemical control and symptom management with CAM2029 in the 52-week ACROINNOVA 2 open-label extensionP266 - ECE_1022 - CAM2029在52周ACROINNOVA 2开放标签扩展研究中的长期安全性、生化控制和症状管理
errEuropean Journal of Endocrinology
IF5.2
err2026-08-10
err0
errOAAI
errDiego Ferone; Beverly M K Biller; Timo Deutschbein; Maria Fleseriu; Mônica Gadelha; Aleksandra Gilis-Januszewska; Pietro Maffei; Robert D Murray; Jochen Seufert; Julie M Silverstein; Jacob Råstam; Maria Harrie; Agneta Svedberg; Alberto M Pedroncelli; Fredrik Tiberg; Joanna L Spencer-Segal
err分享
err收藏
An exploratory trial of a single dose of CAM2043 (treprostinil subcutaneous depot) in SSc-related RPSSc相关RP的单次剂量CAM2043（曲前列尼尔皮下 Depot）探索性试验
errRHEUMATOLOGY
IF4.4
err2025-06-01
err0
errOAAI
errHerrick, Ariane L.; Murray, Andrea; Dinsdale, Graham; Manning, Joanne; Chukwu, Chukwuma; Fernandez, Marcia Alvarez; Axling, Ulrika; Seibold, James R.; Tiberg, Fredrik
err分享
err收藏
Population Pharmacokinetic Analysis of an Octreotide Depot (CAM2029) in the Treatment of Acromegaly奥曲肽缓释制剂（CAM2029）在肢端肥大症治疗中的群体药代动力学分析
errCLINICAL PHARMACOKINETICS
IF4
err2025-05-26
err0
errOAAI
errGlatard, Anais; Friberg-Hietala, Sofia; Keutzer, Lina; Hansson, Anna; Johnsson, Markus; Tiberg, Fredrik
err分享
err收藏
Octreotide Subcutaneous Depot for Acromegaly: A Randomized, Double-blind, Placebo-controlled Phase 3 Trial, ACROINNOVA 1奥曲肽皮下储存治疗肢端肥大症: 一项随机，双盲，安慰剂对照的3期试验，ACROINNOVA 1
errJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
err2024-10-08
err3
errOAAI
errFerone, Diego; Freda, Pamela; Katznelson, Laurence; Gatto, Federico; Kadioglu, Pinar; Maffei, Pietro; Seufert, Jochen; Silverstein, Julie M.; Spencer-Segal, Joanna L.; Isaeva, Elena; Dreval, Alexander; Harrie, Maria; Svedberg, Agneta; Tiberg, Fredrik
err分享
err收藏
Pharmacokinetics and pharmacodynamics of a pasireotide subcutaneous depot (CAM4071) and comparison with immediate and long-acting release pasireotide
errENDOCRINE
IF2.9
err2024-02-29
err0
PREAI
errJohnsson, Markus; Pedroncelli, Alberto M.; Hansson, Anna; Tiberg, Fredrik
err分享
err收藏
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder
errNEUROPSYCHOPHARMACOLOGY
IF7.1
err2024-01-10
err0
errOAAI
errWalsh, Sharon L.; Comer, Sandra D.; Zdovc, Jurij Aguiar; Sarr, Celine; Bjoernsson, Marcus; Strandgarden, Kerstin; Hjelmstrom, Peter; Tiberg, Fredrik
err分享
err收藏
Enzyme encapsulation in nanostructured self-assembled structures: Toward biofunctional supramolecular assemblies
errCURRENT OPINION IN COLLOID & INTERFACE SCIENCE
IF7
err2019-12-01
err13
PREAI
errValldeperas, Maria; Salis, Andrea; Barauskas, Justas; Tiberg, Fredrik; Arnebrant, Thomas; Razumas, Valdemaras; Monduzzi, Maura; Nylandert, Tommy
err分享
err收藏
Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder
errADDICTION
IF5.3
err2019-06-03
err81
errOAAI
errFrost, Michael; Bailey, Genie L.; Lintzeris, Nicholas; Strang, John; Dunlop, Adrian; Nunes, Edward, V; Jansen, Jakob Billeskov; Frey, Lars Chemnitz; Weber, Bernd; Haber, Paul; Oosman, Sonia; Kim, Sonnie; Tiberg, Fredrik
err分享
err收藏
QUALITY OF LIFE ACCORDING TO TEMPORAL ILLICIT OPIOID USE AND RESPONDER RATE IN ADULTS RECEIVING BUPRENORPHINE DEPOT INJECTIONS (CAM2038) TO TREAT OPIOID USE DISORDER IN A 48-WEEK OPEN LABEL STUDY
errVALUE IN HEALTH
IF6
err2018-10-01
err0
errOAAI
errRasmussen, M. A.; Frost, M.; Jensen, R.; Budilovsky, N.; Kim, S.; Tiberg, F.
err分享
err收藏
QUALITY OF LIFE ACCORDING TO RESPONDER RATE IN OPIOID DEPENDENT ADULTS RECEIVING TREATMENT WITH BUPRENORPHINE DEPOT INJECTIONS (CAM2038) VERSUS SUBLINGUAL BUPRENORPHINE/NALOXONE
errVALUE IN HEALTH
IF6
err2018-10-01
err0
errOAAI
errJensen, R.; Rasmussen, M. A.; Frost, M.; Budilovsky, N.; Kim, S.; Tiberg, F.
err分享
err收藏
The lipolytic degradation of highly structured cubic micellar nanoparticles of soy phosphatidylcholine and glycerol dioleate by phospholipase A2 and triacylglycerol lipase
errCHEMISTRY AND PHYSICS OF LIPIDS
IF2.8
err2018-03-01
err10
PREAI
errWadsater, Maria; Barauskas, Justas; Tiberg, Fredrik; Nylander, Tommy
err分享
err收藏
FLEXIBLE-DOSE DEPOT BUPRENORPHINE INJECTION FOR OPIOID SUBSTITUTION TREATMENT IN HEROIN-ADDICTED ADULTS: A SWEDISH PHARMACOECONOMIC PERSPECTIVE
errVALUE IN HEALTH
IF6
err2017-10-01
err1
errOAAI
errJensen, R.; Carter, J. A.; Tiberg, F.; Sanjurjo, V
err分享
err收藏
Pharmacokinetics and pharmacodynamics of a buprenorphine subcutaneous depot formulation (CAM2038) for once-weekly dosing in patients with opioid use disorder
errJOURNAL OF SUBSTANCE ABUSE TREATMENT
IF4
err2017-07-01
err27
PREAI
errHaasen, Christian; Linden, Margareta; Tiberg, Fredrik
err分享
err收藏
Pharmacokinetic Evaluation of Once-Weekly and Once-Monthly Buprenorphine Subcutaneous Injection Depots (CAM2038) Versus Intravenous and Sublingual Buprenorphine in Healthy Volunteers Under Naltrexone Blockade: An Open-Label Phase 1 Study
errADVANCES IN THERAPY
IF4
err2017-01-09
err45
PREAI
errAlbayaty, Muna; Linden, Margareta; Olsson, Hakan; Johnsson, Markus; Strandgarden, Kerstin; Tiberg, Fredrik
err分享
err收藏
Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers
errBRITISH JOURNAL OF CLINICAL PHARMACOLOGY
IF3
err2015-08-06
err51
errOAAI
errTiberg, Fredrik; Roberts, John; Cervin, Camilla; Johnsson, Markus; Sarp, Severine; Tripathi, Anadya Prakash; Linden, Margareta
err分享
err收藏
Non-lamellar lipid liquid crystalline structures at interfaces界面处的非层状脂质液晶结构
errADVANCES IN COLLOID AND INTERFACE SCIENCE
IF19.3
err2015-08-01
err36
PREAI
errChang, Debby P.; Barauskas, Justas; Dabkowska, Aleksandra P.; Wadsater, Maria; Tiberg, Fredrik; Nylander, Tommy
err分享
err收藏
Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model (vol 41, pg 369, 2010)
errEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
IF4.7
err2014-10-01
err0
PREAI
errCervin, Camilla; Tinzl, Martina; Johnsson, Markus; Abrahamsson, Per-Anders; Tiberg, Fredrik; Dizeyi, Nishtman
err分享
err收藏
Formation of Highly Structured Cubic Micellar Lipid Nanoparticles of Soy Phosphatidylcholine and Glycerol Dioleate and Their Degradation by Triacylglycerol Lipase
errACS APPLIED MATERIALS & INTERFACES
IF8.2
err2014-05-07
err69
errOAAI
errWadsater, Maria; Barauskas, Justas; Nylander, Tommy; Tiberg, Fredrik
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
H
Håkan Olsson
H 指数: 101 · 论文数: 905
B
Barry W. Ninham
H 指数: 91 · 论文数: 534
J
John Strang
H 指数: 85 · 论文数: 856
E
Edward V. Nunes
H 指数: 80 · 论文数: 512
B
Bernd Weber
H 指数: 77 · 论文数: 611
查看更多